Advertisement

Gastroenterologia Japonica

, Volume 24, Issue 2, pp 115–119 | Cite as

Inhibitory action of enprostil (4,5-dehydro-16-phenoxy-17,18,19,20-tetranor-PGE2) on tetra-gastrin stimulated acid secretion in human subjects

  • Motoyuki Moriga
  • Mitsuru Aono
  • Hiroaki Narusawa
  • Yoshihiro Kohli
  • Takuji Kato
  • Goro Kajiyama
  • Masaki Inoue
  • Akima Miyoshi
Original Article
  • 5 Downloads

Summary

A double-blind study was conducted to examine the effect of enprostil on tetra-gastrin stimulated gastric acid secretion in twelve healthy male volunteers. Each subject underwent four tests in random order on separate days with oral doses of 15, 25, 35 μg enprostil and placebo. After measuring basal secretion and gastrin release, tetra-gastrin was injected intramuscularly. Gastric secretion and gastrin release were measured over the next two hours. Enprostil dose-dependently inhibited tetragastrin stimulated gastric secretion volume, acid and pepsin output. There were significant differences in gastric acid secretion inhibition between the 15 and 25 μg doses, and the 15 and 35 μg doses, but only a slight dose response was seen between the 25 and 35 μg doses with no significant difference. Serum gastrin level was not influenced by the administration of enprostil. No side effects attributed to enprostil were observed throughout the study.

Key words

Acid Enprostil Gastric secretion Gastrin Pepsin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shay H, Sun DCH: Etiology and pathology of gastric and duodenal ulcer. Gastroenterology 2nd Ed vol I WBSaunders, London. 1964;420Google Scholar
  2. 2.
    Roszkowski AP, Garay GL, Baker S, et al: Gastric antisecretory and antiulcer properties of enprostil, (±)-11α, 15α-dihydroxy-16-phenoxy-17, 18, 19, 20-tetranor-9-oxoprosta-4, 5, 13(t)-trienoic acid methyl ester. J Pharmacol Exp Ther 1986;239: 382–388PubMedGoogle Scholar
  3. 3.
    Hawkey CJ. Simpson G, Somerville KW: Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa. Am J Med 1986;81: 50–53PubMedCrossRefGoogle Scholar
  4. 4.
    Stiel D, Ellard KT, Hills LJ, et al: Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man: comparison with cimetidine and sucralfate. Am J Med 1986;81: 54–58PubMedCrossRefGoogle Scholar
  5. 5.
    Yamagata S, Ishimori A, Sato D, et al: A report of gastric juice measurement study committee: standard gastric juice test method and gastric juice secretion from normal gastric mucus observed by endoscopy. Jpn J Gastroenterol 1983;80: 289–293 (in Jpn)Google Scholar
  6. 6.
    Niwa H, Nakamura T, Muto H, et al: Inhibitory effect of SC-29333, prostaglandin E1 analogue (misoprostol) on gastric secretion, part II: inhibitory effect on stimulated secretion. J Med Pharm Sci 1986;15: 145–157 (in Jpn)Google Scholar
  7. 7.
    Chen FWK, Teck HS, Karim SMM: The effect of 15 (R)-15-methyl prostaglandin E2 on gastric acid secretion in duodenal ulcer patients. Prostaglandins 1977; 13: 115–124PubMedCrossRefGoogle Scholar
  8. 8.
    Hongo M, Asaki S, Hirasawa Y: Inhibitory effect of gastric secretion: stimulated secretion. Gendai Iryo 1987;19: 62–65 (in Jpn)Google Scholar
  9. 9.
    Kawamura T, Ebina H, Koizumi F, et al: Effect of trimoprostil on gastric secretion. Jpn J Clin Pharmacol Ther 1987;18: 347–362 (in Jpn)Google Scholar
  10. 10.
    Buchanan N, Laferla G, Hearns J, et al: Effect of a single oral dose of enprostil on gastric secretion and gastrin release: studies in healthy volunteers and patients with pernicious anemia. Am J Med 1986;81: 40–43PubMedCrossRefGoogle Scholar
  11. 11.
    Thomson ABR, Mahachai V, Walker K, et al: Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease. Gastroenterology 1985;89: 555–561PubMedGoogle Scholar
  12. 12.
    Thomas FJ, Koss MA, Hogan DL, et al: Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer. Am J Med 1986;81: 44–49PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society of Gastroenterology 1989

Authors and Affiliations

  • Motoyuki Moriga
    • 1
  • Mitsuru Aono
    • 1
  • Hiroaki Narusawa
    • 1
  • Yoshihiro Kohli
    • 2
  • Takuji Kato
    • 2
  • Goro Kajiyama
    • 3
  • Masaki Inoue
    • 3
  • Akima Miyoshi
    • 4
  1. 1.First Department of Internal MedicineKyoto University Faculty of MedicineKyotoJapan
  2. 2.Second Department of Internal MedicineFukui Medical CollegeFukuiJapan
  3. 3.First Department of Internal MedicineHiroshima University School of MedicineHiroshimaJapan
  4. 4.Hamamatsu Medical Care CenterHamamatsuJapan

Personalised recommendations